CCDC159
Coiled-coil domain-containing protein 159
Also known as: CC159_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P0C7I6
- Gene
- CCDC159
- Ensembl
- ENSG00000183401
- Chromosome
- 19
- Canonical length
- 297 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Cytosol
OverviewNCBI Gene
Predicted to be involved in spermatid development. Predicted to act upstream of or within several processes, including regulation of phosphatase activity; single fertilization; and sperm flagellum assembly. Predicted to be located in sperm head-tail coupling apparatus. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
297 residues, UniProt reviewed canonical sequence.
>P0C7I6|CCDC159
1 MGEHEQVKPL ETSSSKVKAK TIVMIPDSQK LLRCELESLK SQLQAQTKAF EFLNHSVTML
61 EKESCLQQIK IQQLEEVLSP TGRQGEKEEH KWGMEQGRQE LYGALTQGLQ GLEKTLRDSE
121 EMQRARTTRC LQLLAQEIRD SKKFLWEELE LVREEVTFIY QKLQAQEDEI SENLVNIQKM
181 QKTQVKCRKI LTKMKQQGHE TAACPETEEI PQGASGCWKD DLQKELSDIW SAVHVLQNSI
241 DSLTLCSGAC PKASSLRGHK GHQCLSPPLP SWDSDSDCDQ DLSQPPFSKS GRSFPPALocalizationUniProt · AlphaFold · HPA
Whether an antibody against CCDC159 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.56
- Highest tissue expression
- 45 nTPM
Expression across tissuesHPA
Tissue
- prostate: 45 nTPM
- adrenal gland: 43 nTPM
- spinal cord: 43 nTPM
- testis: 42 nTPM
- spleen: 41 nTPM
- parathyroid gland: 37 nTPM
Single-cell type
- late spermatids: 378 nCPM
- early spermatids: 370 nCPM
- cardiomyocytes: 199 nCPM
- epicardial cells: 71 nCPM
- late primary spermatocytes: 37 nCPM
- epididymal principal cells: 34 nCPM
Immune cell
- classical monocyte: 53 nTPM
- basophil: 52 nTPM
- intermediate monocyte: 46 nTPM
- eosinophil: 39 nTPM
- non-classical monocyte: 34 nTPM
- myeloid DC: 32 nTPM
Brain region
- white matter: 44 nTPM
- cerebral cortex: 43 nTPM
- medulla oblongata: 37 nTPM
- thalamus: 36 nTPM
- pons: 36 nTPM
- basal ganglia: 35 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.9
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.49
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CCDC159 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CCDC159 as an antibody target. Whether an autoantibody or antibody against CCDC159 could matter depends on whether native CCDC159 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CCDC159 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CCDC159 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...